WHO |
World Health Organization |
HGG |
high-grade glioma |
CNS |
central nervous system |
BBB |
blood–brain barrier |
OV |
oncolytic virus |
Treg
|
regulatory T cell |
MDSC |
myeloid-derived suppressor cell |
NK |
natural killer |
PAMP |
pathogen-associated molecular pattern |
PRR |
pattern recognition receptor |
DAMP |
damage-associated molecular patterns |
GM-CSF |
granulocyte macrophage colony-stimulating factor |
CTLA-4 |
cytotoxic T-lymphocyte associated protein 4 |
PD-1 |
programmed cell death protein-1 |
HSV |
herpes simplex virus |
FDA |
Food and Drug Administration (of the United States) |
CPA |
cyclophosphamide |
TMZ |
temozolomide |
CD |
cytosine deaminase |
5-FU |
5-fluorouracil |
CEA |
carcinoembryogenic antigen |
ECM |
extracellular matrix |